Novel inhibitors of RNA synthesis

S. B. Horwitz

Research output: Contribution to journalReview articlepeer-review

13 Scopus citations

Abstract

Many cancer chemotherapeutic agents inhibit nucleic acid synthesis but their mechanisms of action differ widely. Five drugs that inhibit synthesis of RNA are examined in this paper. Anthramycin, camptothecin and bleomycin act at the level of the DNA template. Anthramycin and camptothecin were studied in HeLa cells and bleomycin in vaccinia virus infected HeLa cells. Anthramycin forms a strong complex with DNA while camptothecin and bleomycin interfere with template function by virtue of their ability to degrade DNA. Gallin, a triphenylmethane dye that is active only in vitro, inhibits RNA synthesis by binding to Escherichia coli RNA polymerase. Steganangin is an example of an inhibitor of RNA synthesis in HeLa cells that acts at the substrate level.

Original languageEnglish (US)
Pages (from-to)2281-2287
Number of pages7
JournalFederation Proceedings
Volume33
Issue number11
StatePublished - 1974
Externally publishedYes

ASJC Scopus subject areas

  • General Medicine

Fingerprint

Dive into the research topics of 'Novel inhibitors of RNA synthesis'. Together they form a unique fingerprint.

Cite this